PUBLISHER: Grand View Research | PRODUCT CODE: 1750734
PUBLISHER: Grand View Research | PRODUCT CODE: 1750734
The global canine atopic dermatitis market size is anticipated to reach USD 8.78 billion by 2030 and expand at a CAGR of 10.6% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of canine atopic dermatitis and advancements in veterinary medicine are driving market growth. Increasing cases of skin allergies in dogs have led to higher demand for effective treatments. Innovations such as monoclonal antibodies and improved immunosuppressants enhance therapeutic outcomes, fueling market expansion. Research and development efforts continue to drive novel therapies, improving treatment efficacy and accessibility.
Growing pet ownership and increased awareness among pet owners propel the canine atopic dermatitis market. As more households adopt dogs, the demand for dermatological care rises. Pet owners are becoming more proactive in seeking treatment, leading to higher adoption of specialized therapies. The rise in pet healthcare spending and improved diagnostic capabilities further contribute to market growth.
The increasing focus on companion animal wellness and expanding veterinary healthcare infrastructure are expected to drive market growth. Enhanced veterinary facilities and specialized dermatology clinics improve access to advanced treatments. Rising investments in pet healthcare further support the market expansion, with pharmaceutical companies developing innovative solutions to meet growing demand.